166 related articles for article (PubMed ID: 2139848)
1. The possibility that pancreatic beta cell destruction leading to type 1 diabetes is initiated by the release of cytokines by polyclonal activation of the immune system.
Ziegler M; Ziegler B
Exp Clin Endocrinol; 1990 Feb; 95(1):110-8. PubMed ID: 2139848
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune response directed to pancreatic beta cells in rats induced by combined treatment with low doses of streptozotocin and complete Freund's adjuvant.
Ziegler M; Ziegler B; Hehmke B; Dietz H; Hildmann W; Kauert C
Biomed Biochim Acta; 1984; 43(5):675-81. PubMed ID: 6236801
[TBL] [Abstract][Full Text] [Related]
3. Destruction of pancreatic beta cells in rats by complete Freund's adjuvant combined with non-diabetogenic doses of streptozotocin.
Kohnert KD; Odselius R; Fält K; Ziegler B; Ziegler M; Falkmer S
Diabetes Res; 1987 May; 5(1):1-11. PubMed ID: 2957141
[TBL] [Abstract][Full Text] [Related]
4. Cellular and humoral autoimmunity in insulin-dependent diabetes mellitus.
Scherbaum WA; Seissler J
Exp Clin Endocrinol Diabetes; 1995; 103 Suppl 2():88-94. PubMed ID: 8839261
[TBL] [Abstract][Full Text] [Related]
5. Genetic control of susceptibility to severe hyperglycaemia evoked by CFA/SZ-induced immune response against beta cells in various rat strains.
Ziegler M; Ziegler B; Kohnert KD; Klöting I
Biomed Biochim Acta; 1988; 47(4-5):337-42. PubMed ID: 2977097
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune disorders in diabetes.
Boitard C; Debray-Sachs M; Bach JF
Adv Nephrol Necker Hosp; 1986; 15():281-305. PubMed ID: 3082114
[TBL] [Abstract][Full Text] [Related]
7. [Autoimmunity and insulin-dependent diabetes mellitus. Experimental data and therapeutic prospects].
Thivolet C; Khallouf E
Pediatrie; 1989; 44(4):247-57. PubMed ID: 2677968
[TBL] [Abstract][Full Text] [Related]
8. On the pathogenesis of type 1 (insulin-dependent) diabetes mellitus: facts, areas still under development and new perspectives.
Bottazzo GF; Bonifacio E; Wagner R; al-Sakkaf L; Dean BM; Mirakian R
Klin Wochenschr; 1990; 68 Suppl 21():26-37. PubMed ID: 2198388
[TBL] [Abstract][Full Text] [Related]
9. [Detection of antibodies against pancreatic islet cells in clinical practice].
Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
[TBL] [Abstract][Full Text] [Related]
10. Islet-infiltrating T cell clones from non-obese diabetic mice that promote or prevent accelerated onset diabetes.
Pankewycz O; Strom TB; Rubin-Kelley VE
Eur J Immunol; 1991 Apr; 21(4):873-9. PubMed ID: 1902177
[TBL] [Abstract][Full Text] [Related]
11. Impact of genetic and non-genetic factors in type 1 diabetes.
Hawa MI; Beyan H; Buckley LR; Leslie RD
Am J Med Genet; 2002 May; 115(1):8-17. PubMed ID: 12116172
[TBL] [Abstract][Full Text] [Related]
12. Effects of environmental factors on the development of insulin-dependent diabetes mellitus.
Yoon JW; Kim CJ; Pak CY; McArthur RG
Clin Invest Med; 1987 Sep; 10(5):457-69. PubMed ID: 3315367
[TBL] [Abstract][Full Text] [Related]
13. Immunological disorders of type 1 diabetes mellitus.
Ziegler M; Ziegler B
Exp Clin Endocrinol; 1989 Sep; 94(1-2):97-114. PubMed ID: 2689194
[TBL] [Abstract][Full Text] [Related]
14. Immunological reversal of autoimmune diabetes without hematopoietic replacement of beta cells.
Suri A; Calderon B; Esparza TJ; Frederick K; Bittner P; Unanue ER
Science; 2006 Mar; 311(5768):1778-80. PubMed ID: 16556846
[TBL] [Abstract][Full Text] [Related]
15. [Etiology and pathogenesis of type I diabetes].
Ziegler AG
Z Gesamte Inn Med; 1993 Mar; 48(3):100-7. PubMed ID: 8475631
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-1 beta induced transient diabetes mellitus in rats. A model of the initial events in the pathogenesis of insulin-dependent diabetes mellitus?
Reimers JI
Dan Med Bull; 1998 Apr; 45(2):157-80. PubMed ID: 9587701
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
Gallichan WS; Balasa B; Davies JD; Sarvetnick N
J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
[TBL] [Abstract][Full Text] [Related]
18. Genetic control of diabetes induction by complete Freund's adjuvant combined with subdiabetogenic doses of streptozotocin in Lewis rats--evidence for transient cytotoxicity against beta cells.
Ziegler B; Tietz S; Kohnert KD; Köhler E; Knospe S; Klöting I; Ziegler M
Exp Clin Endocrinol; 1987 Aug; 89(3):269-75. PubMed ID: 2959492
[TBL] [Abstract][Full Text] [Related]
19. Pathological changes in the islet milieu precede infiltration of islets and destruction of beta-cells by autoreactive lymphocytes in a transgenic model of virus-induced IDDM.
von Herrath M; Holz A
J Autoimmun; 1997 Jun; 10(3):231-8. PubMed ID: 9218748
[TBL] [Abstract][Full Text] [Related]
20. C. L. Oakley lecture (1987). The pathogenesis of beta cell destruction in type I (insulin-dependent) diabetes mellitus.
Foulis AK
J Pathol; 1987 Jul; 152(3):141-8. PubMed ID: 3309229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
